BHVN
Biohaven Ltd.Marquee-fund ownership over time
This quarter's activity
New positions opened
Positions exited
None.
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Citadel Advisors | Q3 2024(8Q snapshot) | 7Q | $0.00 | $10 | — |
| Two Sigma Investments | Q3 2024(8Q snapshot) | 7Q | $0.00 | $10 | — |
| D.E. Shaw | Q3 2024(8Q snapshot) | 7Q | $0.00 | $10 | — |
| AQR Capital Management | Q3 2024(8Q snapshot) | 7Q | $0.00 | $10 | — |
| Millennium Management | Q3 2024(8Q snapshot) | 7Q | $0.00 | $10 | — |
| Point72 Asset Management re-entered | Q3 2024(8Q snapshot) | 7Q | $0.00 | $10 | — |
| Renaissance Technologies re-entered | Q1 2025(8Q snapshot) | 5Q | $0.00 | — | — |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Bridgewater Associates 2× in & out | Q4 2025 | Q1 2026 | → $11 | +41% |
| Viking Global Investors | Q1 2022 | Q3 2022 | — | +0% |
| Glenview Capital 2× in & out | Q2 2021 | Q3 2022 | — | +0% |
| Maverick Capital | Q3 2021 | Q1 2022 | — | +0% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at Biohaven Ltd.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from Apr 30, 2026 — the most recent Form 4 on file — not from today.
- Form 40001850520-26-000005Apr 30, 2026
- Form 40001329505-26-000005Apr 30, 2026
- Form 40001448914-26-000002Apr 30, 2026
- Form 40001926476-26-000002Apr 30, 2026
- Form 40001027035-26-000008Apr 30, 2026
- Form 40001232505-26-000003Apr 30, 2026
- Form 40001226675-26-000002Apr 30, 2026
- Form 40001850520-26-000003Mar 19, 2026
- Form 4/Aamend0001027035-26-000006Mar 9, 2026
- Form 40001898799-26-000004Mar 3, 2026
- Form 40001704186-26-000004Mar 3, 2026
- Form 40001878290-26-000004Mar 3, 2026
- Form 40001798876-26-000004Mar 3, 2026
- Form 40001704317-26-000004Mar 3, 2026
- Form 40001704186-26-000002Jan 7, 2026
Fundamentals
XBRL · Biohaven Ltd.Annual figures sourced directly from Biohaven Ltd.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for Biohaven Ltd. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 8-KMaterial eventMay 27, 2026
- 8-KMaterial eventMay 5, 2026
- 10-QQuarterly reportMay 4, 2026
- 8-KMaterial eventMay 4, 2026
- 8-KMaterial eventMay 4, 2026
- DEF 14AProxy statementMar 13, 2026
- 8-KMaterial eventMar 2, 2026
- 10-KAnnual reportMar 2, 2026
- 8-KMaterial eventJan 12, 2026
- 8-KMaterial eventJan 7, 2026
- 8-KMaterial eventNov 13, 2025
- 10-QQuarterly reportNov 10, 2025
- 8-KMaterial eventNov 10, 2025
- 8-KMaterial eventAug 22, 2025
- 8-KMaterial eventAug 15, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Renaissance Technologies | Q2 2026 | open | $0.00 | — | +0% |
| Point72 Asset Management | Q4 2025 | open | $0.00 | — | +0% |
| Bridgewater Associates | Q4 2025 | Q1 2026 | $8.08 | $11 | +41% |
| Renaissance Technologies | Q1 2025 | Q3 2025 | $0.00 | — | +0% |
| Citadel Advisors | Q3 2024 | open | $0.00 | — | +0% |
| Two Sigma Investments | Q3 2024 | open | $0.00 | — | +0% |
| D.E. Shaw | Q3 2024 | open | $0.00 | — | +0% |
| AQR Capital Management | Q3 2024 | open | $0.00 | — | +0% |
| Millennium Management | Q3 2024 | open | $0.00 | — | +0% |
| Point72 Asset Management | Q3 2024 | Q2 2025 | $0.00 | — | +0% |
| Bridgewater Associates | Q1 2022 | Q1 2023 | $0.00 | — | +0% |
| Viking Global Investors | Q1 2022 | Q3 2022 | $0.00 | — | +0% |
| Maverick Capital | Q3 2021 | Q1 2022 | $0.00 | — | +0% |
| Glenview Capital | Q2 2021 | Q3 2022 | $0.00 | — | +0% |
| Glenview Capital | Q3 2020 | Q1 2021 | $0.00 | — | +0% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.